CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Sotatercept for the Treatment of Pulmonary Arterial Hypertension Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Pancoronary Plaque Characteristics in STEMI Caused by Culprit Plaque Erosion Versus Rupture: 3-Vessel OCT Study Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and D6PK C-reactive protein and prognosis after percutaneous coronary intervention and bypass graft surgery for left main coronary artery disease: Analysis from the EXCEL trial Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction

Editorial2017 Dec 12;70(23):2875-2877.

JOURNAL:J Am Coll Cardiol. Article Link

Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device?

King SB 3rd, Gogas BD. Keywords: bioresorbable vascular scaffold; prognosis; randomized trial; stent; technique; thrombosis

FULL TEXT PDF